New claims-sourced RADAR models demonstrate positive predictive value BOSTON, Jan. 7, 2025 /PRNewswire/ -- Together Senior Health (Together), a Linus Health...
STOCKHOLM, Jan. 7, 2025 /PRNewswire/ -- RaySearch Laboratories AB (publ) today announces that the Polish company Medim has placed an...
Oncology Quality Hub Recognized for MIPS Clinical Data Reporting NASHVILLE, Tenn., Jan. 7, 2025 /PRNewswire/ -- OneOncology, the physician-led platform...
Coeptis Secures Five New Clients With Total Contract Value of $1.7 Million Dollars With More On The Horizon Signaling AI-Driven...
Verismo will receive up to $4.05 million USD in investments from the Institute for Follicular Lymphoma Innovation (IFLI).The partnership with...
Magdalena aiming to submit Investigational New Drug (IND) application in early 2025 to the FDA for a next-generation psychoactive prescription...
MIAMI, FL / ACCESSWIRE / January 7, 2025 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir"), an emerging leader in age-reversal science...
GAITHERSBURG, Md., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development...
Over 300 Participants Have Completed Cumulative Six Months of Cytisinicline Treatment in the ORCA-OL Trial, Completing the Long-Term Exposure Requirement...
QUANTRO’s proprietary time-resolved functional transcriptomic discovery platform accelerates target screening for complex indications in oncology and inflammationQUANTRO CEO Dr. Michael...
AUSTIN, Texas, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Erisyon, a leading provider of single-molecule proteomics technology, today announced that it...
JERUSALEM, Jan. 7, 2025 /PRNewswire/ -- Senseera, a liquid biopsy company pioneering chromatin epigenomics, announced the successful close of a...
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in...
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in...
Independent director, Jim Alecxih, Chief Executive Officer of DH Medical joins Lumicell's Board of Directors NEWTON, Mass., Jan. 6, 2025...
Bringing decades of clinical leadership to advance symplr's healthcare operations solutions and support patient-centered care HOUSTON, Jan. 6, 2025 /PRNewswire/...
Proceeds from the financing will be used to broaden and improve the company's offerings and for operational expansion across facilities,...
NORTHAMPTON, MA / ACCESSWIRE / January 6, 2025 / Clinical trials are essential for the development of health care products,...
– Approximately $10 million additional investment in private placement equity financing – – $1.5 million from CIRM grant first announced...
SEATTLE and VANCOUVER, British Columbia, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical...